Pharma > Nova Content
Written by Daniel K. Yarbrough, Ph.D. and Nathanael R. Luman, Ph.D.
The PTAB denied institution of an IPR based on patent owner’s challenge to the prior art ... Read More »
By Barry Herman
By now, most everyone in the patent community has heard about the $2.54 Billion dollar jury verdict in a battle over Hepatitis C medication that... Read More »
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D.
On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. f. 3d 1347 (Fed. Cir... Read More »
Written by Jane Xia and Jason J. Jardine
Every year, the FDA’s Center for Drug Evaluation and Research (CDER) approves new medications. Some medications are ... Read More »
Currently there are two competing patent reform bills making the rounds in Congress: Representative Goodlatte’s Innovation Act of 2015 and the Strong Patent Act ... Read More »
Penicillin, teflon, plastic, and now nanoparticles; all breakthrough discoveries stemming from scientific “failures.” University of Central Florida... Read More »
In... and out. In... and out. Air flows through the narrow channel carved into the small silicon chip, blood pumping, the miniature lung embedded inside breaths... Read More »
Mobile health apps are developing quickly, and they aim to replace and/or complement treatments prescribed by doctors. The newest app on the block is Happitique. This ... Read More »
Here’s the top medical news of this week!
Promising new HIV treatments give hope for eventual cure
The Human Immunodeficiency Virus (HIV)... Read More »
This week, Roche announced it has discontinued development of its cholesterol drug dalcetrapib, marking the end of the story for a drug once touted as a potential... Read More »
Two Michigan State University researchers have invented a protein purifier that will make pharmaceutical production quicker and cheaper. Chemists Merlin... Read More »
Ever wonder what happens to medical hazardous waste? When research and health care facilities dispose of hazardous waste, there are certain guidelines --... Read More »
The more innovative you are, the more you’re worth. The 2011 salary survey published by The Scientist reported that the highest paid science careers are in... Read More »
Janssen Biotech announced today that it has negotiated an agreement with Pharmacyclics to develop and market PCI-32765, an anti-cancer compound. Janssen Biotech, a... Read More »
Pfizer Inc, and San Diego based Excaliard Pharmaceuticals, Inc, have entered into an agreement where Pfizer will privately acquire Excaliard. Pfizer said it... Read More »
CHICAGO (Reuters) - An experimental drug that chokes off the blood supply to fat cells helped obese monkeys slim down, a sign that it may work in people... Read More »
Pfizer Inc recently announced the results for the efficacy of the drug Toviaz that has been under study. The study (Study A0221048) was conducted to test... Read More »
Two major pharmaceutical companies, Amylin Pharmaceuticals Inc (“Amylin”) and Eli Lilly and Company (“Lilly”), announced today their plans to... Read More »
Abbott announced today, at the American College of Rheumatology Annual Scientific Meeting in Chicago, the results of their Phase-3 ABILITY-1 trial... Read More »
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »